Related Experiment Video
Updated: Feb 13, 2026

Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions
Published on: September 17, 2014
Magnesium valproate-induced pedal edema on chronic therapy: A rare adverse drug reaction
Himani Prajapati1, Dinesh Kansal1, Rajan Negi2
1Department of Pharmacology, Dr. Rajendera Prasad Government Medical College, Kangra at Tanda, Himachal Pradesh, India.
Abstract:
Valproate-related pedal edema is usually regarded as a problem occurring after long-term administration of valproate. Valproate has been a drug of choice for the treatment of generalized or partial seizures as monotherapy or adjunctive therapy, bipolar disorder, for the prophylaxis of migraine headache in adults. This case report described patient-acquiring bilateral pedal edema after long-term use of magnesium valproate. Discontinuing valproate resulted in rapid improvement of the condition. This adverse reaction to the best of our knowledge is first reported a case of bilateral pedal edema cause by magnesium valproate in low dose. The dose of magnesium valproate was 1200 mg/day. No previous case as reported with the same dose.
More Related Videos
Related Concept Videos
Drug Therapy
Antianxiety Medications
Allergic Drug Reactions
Drug Toxicity: Allergic Reactions
Reaction Yield
Drug Metabolism: Phase I Reactions
Drug Metabolism: Phase II Reactions

